Behçet Cihat Şahal

Behnoush Hajian is a Senior Scientist I at the Broad Institute of MIT and Harvard, where contributions have been made since February 2019 in the Center for Development of Therapeutics, following previous roles as Research Scientist II and Research Scientist I. Prior experience includes serving as a Research Assistant at the University of Connecticut from August 2012 to January 2019, focusing on the development of small molecules as inhibitors for tuberculosis and dual inhibitors targeting both Streptococcus pyogenes and Staphylococcus aureus. Additionally, Behnoush was a Graduate Teaching Assistant, instructing courses related to drug information, dosage form preparation, nutrition, and problem-solving in pharmacy. Educational qualifications include a Doctor of Philosophy (PhD) in Pharmaceutical Sciences with a focus on Medicinal Chemistry and Drug Design from the University of Connecticut, a Master of Science (M.Sc.) in Biotechnology from Bu-Ali Sina University, and a Bachelor of Science (B.Sc.) in Plant Pathology/Phytopathology from Shiraz University.